article thumbnail

Glass specialist Schott Pharma touts 2023 sales growth, Serbia expansion and hiring plans

Fierce Pharma

Following an IPO and ahead of its fiscal 2023 earnings release next month, German drug containment and delivery specialist Schott Pharma is trumpeting its recent momentum. | Following an IPO and ahead of its fiscal 2023 earnings release next month, pharma glass specialist Schott Pharma is trumpeting its recent momentum.

Pharma 212
article thumbnail

Executive Interviews at Digital Pharma East 2023

Fierce Pharma

Fierce Pharma sits down with digital marketing leaders to discuss this year's most innovative topics at Digital Pharma East. Fierce Pharma sits down with digital marketing leaders to discuss this year's most innovative topics at Digital Pharma East. Learn more by watching the videos below.

Pharma 215
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Grifols jumps pharma's 2023 layoff queue with plans to scrap 2,300 jobs, primarily in the US

Fierce Pharma

Grifols jumps pharma's 2023 layoff queue with plans to scrap 2,300 jobs, primarily in the US fkansteiner Wed, 02/15/2023 - 17:20

Pharma 237
article thumbnail

2023 forecast: FDA revamps cancer drug approvals, and Big Pharma is willing to fall in line

Fierce Pharma

2023 forecast: FDA revamps cancer drug approvals, and Big Pharma is willing to fall in line. Sun, 12/18/2022 - 17:18.

Pharma 266
article thumbnail

Novo Nordisk, AstraZeneca and Lilly will top pharma's revenue growth in 2023: report

Fierce Pharma

Novo Nordisk, AstraZeneca and Lilly will top pharma's revenue growth in 2023: report. Thu, 01/05/2023 - 16:33.

Pharma 220
article thumbnail

With Pfizer struggling in 2023, CEO Bourla hit with 35% pay cut to $21.6M

Fierce Pharma

Pfizer knew 2023 was going to be a challenging year of transition. But even the drugmaker was surprised by the plummeting demand for its COVID-19 products, missing badly on its 2023 guidance. million in 2023. . million in 2023.

363
363
article thumbnail

Will Big Pharma engage in Medicare price negotiations? The verdict's not in

Fierce Pharma

Will Big Pharma engage in Medicare price negotiations? The verdict's not in zbecker Wed, 09/27/2023 - 10:40

Pharma 299